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Manfred KayserHow nice, I thought as a child, would it be to not feel
physical pain. Later I realized that sense of pain may
exist for a reason; it was suggested that physical pain has
evolved as an alarm system to protect the body from ser-
ious damage. Much later I read about human disorders
involving severe insensitivity to physical pain. Still, the
idea of not feeling pain remains appealing (especially an-
ticipating my coming years when some painful age-
related health problems are likely to kick in).
Previously, it was demonstrated that a loss-of-function
mutation in the sodium ion channel gene SCN9A leads
to the inability to experience pain [1]. In a more recent
study, Leipold et al. [2] identified another sodium ion
channel gene, SCN11A, which, when harboring a par-
ticular missense mutation, causes loss of pain percep-
tion. SCN11A encodes the voltage-gated sodium ion
channel NAv1.9, which is highly expressed in nocicep-
tors (i.e., neurons that transmit sensory information
from the body periphery to the spinal cord). The authors
started out with whole-exome sequencing of healthy
German parents and their child diagnosed with the con-
genital inability to experience pain. A heterozygote non-
synonymous mutation in SCN11A was identified as the
only de novo event detected in this affected child. Aim-
ing to confirm this finding in independent samples, the
authors performed Sanger sequencing of SCN11A exons
in 58 additional individuals diagnosed with early-onset
severe sensory loss, most of them representing sporadic
cases. One Swedish individual showed the very same
heterozygous SCN11A mutation, and the clinical history
of both individuals was also similar. From these findings,
the authors hypothesized that the identified mutation
that leads to a replacement of leucine with proline (p.
Leu811Pro) at the distal end of one of the transmem-
brane segments in domain II of NAv1.9 is disease caus-
ing and leads to loss of pain perception.
Seeking molecular proof, the authors introduced the
orthologous alteration (Leu799Pro) into the mouse Scn11a
gene, but found no obvious morphological changes inCorrespondence: m.kayser@erasmusmc.nl
Department of Forensic Molecular Biology, Erasmus MC University Medical
Centre Rotterdam, PO Box 2040, Rotterdam, CA 3000, The Netherlands
© 2014 Kayser; licensee BioMed Central Ltd. T
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.sensory axons or in nerve fibers in the skin of the viable
heterozygote knock-in mice. However, 11% of the knock-in
mice had severe lesions that were not observed in the wild-
type mice. Since the lesions also appeared in knock-in mice
housed solitarily, it was assumed that they were self-
inflicted. Also other experimental evidence pointed to-
wards reduced pain sensitivity in these knock-in mice.
Because NAv1.9 had been suggested to influence the ex-
citability of dorsal root ganglia (DRG) neurons (i.e., their
property to react to stimulation), the authors then investi-
gated the electrical potential of DRG neurons isolated from
wild-type and mutant mice. They found that a significant
fraction of the mutant channels were active under resting
conditions, and that the duration of action potentials was
significantly reduced in the mutant neurons compared
with wild-type neurons. In knock-out mice, however, only
a minor effect on action potentials was observed. Add-
itional experiments showed that the excessive activity at
resting conditions caused sustained depolarization of noci-
ceptors, impaired generation of action potentials and aber-
rant synaptic transmission.
To study the effect of the mutation further, the au-
thors heterologously expressed human NAv1.9 and
NAv1.9 Leu811Pro mutant channels in ND7/23 cells
(i.e., a mouse neuroblastoma x rat neuron hybrid cell
line). They found that the phenotype of human NAv1.9
Leu811Pro mutant channels resembled that of mouse
NAv1.9 Leu799Pro mutant channels, except in terms of
steady-state inactivation. From the weak influence of the
mutation on inactivation in the human channel, they con-
cluded a stronger gain-of-function effect in humans than
in knock-in mice.
Besides impressively demonstrating the power of whole-
exome sequencing to find rare candidate disease causing
mutations, this study provides a new gain-of-function view
on the molecular basis of pain loss, which was previously
linked to loss-of-function mutations such as in the NAv1.7
channel encoded by SCN9A [1]. Furthermore, this finding
may open up new avenues for the development of new
painkilling drugs [3].his is an Open Access article distributed under the terms of the Creative
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